• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFR14A filed by Celanese Corporation

    3/24/25 4:51:23 PM ET
    $CE
    Major Chemicals
    Industrials
    Get the next $CE alert in real time by email
    DEFR14A 1 ce-2025defr14a.htm DEFR14A Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 14A
    (Rule 14a-101)

    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934
    (Amendment No. 1)

    Filed by the Registrant þ
    Filed by a Party other than the Registrant ¨
    Check the appropriate box:
    ¨  Preliminary Proxy Statement
    ¨  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    ¨  Definitive Proxy Statement
    þ  Definitive Additional Materials
    ¨  Soliciting Material Pursuant to §240.14a-12
    CELANESE CORPORATION
    (Name of Registrant as Specified In Its Charter)
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)
    Payment of Filing Fee (Check the appropriate box):
    þ  
    No fee required
     
    ¨  
    Fee paid previously with preliminary materials.
    ¨  
    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.




    EXPLANATORY NOTE
    On March 24, 2025, Celanese Corporation (“Celanese” or the “Company”) filed with the U.S. Securities and Exchange Commission its Definitive Proxy Statement on Schedule 14A (the “Proxy Statement”) and its Definitive Additional Materials (the “Additional Materials”) for its Annual Meeting of Shareholders to be held on May 14, 2025. Celanese is filing a revised form of proxy card and notice of internet availability solely to correct an inadvertent omission on the originally filed versions. This Amendment No. 1 to the Proxy Statement and the Additional Materials supersedes in its entirety only (i) the enclosed proxy card to the Proxy Statement and (ii) the notice of internet availability included in the Additional Materials, each of which is updated on the following pages.



    celanesecorporation_vxprxy.jpg



    celanesecorporation_vxprxya.jpg



    celanesecorporation_vxnaxp.jpg



    celanesecorporation_vxnaxpa.jpg


    Get the next $CE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CE

    DatePrice TargetRatingAnalyst
    6/16/2025$66.00Equal Weight → Overweight
    Wells Fargo
    5/20/2025$55.00Underperform → Market Perform
    BMO Capital Markets
    3/21/2025$76.00Sector Weight → Overweight
    KeyBanc Capital Markets
    3/17/2025$70.00Neutral → Overweight
    Alembic Global Advisors
    3/6/2025$66.00Sell → Hold
    Vertical Research
    2/20/2025$84.00 → $56.00Outperform → Sector Perform
    RBC Capital Mkts
    1/14/2025$95.00 → $88.00Underperform → Buy
    BofA Securities
    11/11/2024$161.00 → $97.00Buy → Neutral
    UBS
    More analyst ratings

    $CE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP - Acetyls Murray Mark Christopher bought $77,174 worth of shares (1,479 units at $52.18), increasing direct ownership by 11% to 15,468 units (SEC Form 4)

      4 - Celanese Corp (0001306830) (Issuer)

      5/28/25 4:18:51 PM ET
      $CE
      Major Chemicals
      Industrials
    • Director Moorthy Ganesh bought $53,290 worth of shares (1,000 units at $53.29) (SEC Form 4)

      4 - Celanese Corp (0001306830) (Issuer)

      3/13/25 4:47:56 PM ET
      $CE
      Major Chemicals
      Industrials
    • Director Sutton Scott Mcdougald bought $407,119 worth of shares (7,450 units at $54.65), increasing direct ownership by 99% to 15,000 units (SEC Form 4)

      4 - Celanese Corp (0001306830) (Issuer)

      3/10/25 5:17:56 PM ET
      $CE
      Major Chemicals
      Industrials

    $CE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP - Acetyls Murray Mark Christopher bought $77,174 worth of shares (1,479 units at $52.18), increasing direct ownership by 11% to 15,468 units (SEC Form 4)

      4 - Celanese Corp (0001306830) (Issuer)

      5/28/25 4:18:51 PM ET
      $CE
      Major Chemicals
      Industrials
    • Director Koenig Michael covered exercise/tax liability with 335 shares, decreasing direct ownership by 5% to 6,358 units (SEC Form 4)

      4 - Celanese Corp (0001306830) (Issuer)

      5/19/25 4:20:29 PM ET
      $CE
      Major Chemicals
      Industrials
    • Director Rucker Kim K.W. returned 1,114 shares to the company, decreasing direct ownership by 25% to 3,432 units (SEC Form 4)

      4 - Celanese Corp (0001306830) (Issuer)

      5/19/25 8:01:17 AM ET
      $CE
      Major Chemicals
      Industrials